Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 542925, 3 pages
http://dx.doi.org/10.1155/2010/542925
Case Report

Peripheral Neuropathy and VIth Nerve Palsy Related to Randall Disease Successfully Treated by High-Dose Melphalan, Autologous Blood Stem Cell Transplantation, and VIth Nerve Decompression Surgery

1Service de Gériatrie, Hôpital Jean Minjoz, CHU, Boulevard Fleming, 25000 Besançon Cedex, France
2Service de Médecine Interne Gériatrie, Hôpital de Champmaillot, CHU BP 87909, 2 rue Jules Violle, 21079 Dijon Cedex, France
3INSERM/U887 Motricité-Plasticité: Performance, Dysfonctionnement, Vieillissement et Technologies d'optimisation, Université de Bourgogne, BP 27877, 21078 Dijon Cedex, France
4Service de Médecine Interne, Hôpital Jean Minjoz, CHU, Boulevard Fleming, 25000 Besançon Cedex, France

Received 11 September 2010; Revised 14 November 2010; Accepted 17 November 2010

Academic Editor: Shaji Kumar

Copyright © 2010 C. Foguem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Randall, W. C. Williamson Jr., F. Mullinax et al., “Manifestations of systemic light chain deposition,” American Journal of Medicine, vol. 60, no. 2, pp. 293–299, 1976. View at Google Scholar · View at Scopus
  2. P. A. Zakrzewski, E. Weis, V. A. White, and J. Rootman, “Intracellular extraocular muscle light- and heavy-chain deposition disease contributing to compressive optic neuropathy in a patient with preexisting graves' orbitopathy,” Ophthalmologica, vol. 224, no. 1, pp. 59–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Ronco, M. A. Alyanakian, B. Mougenot, and P. Aucouturier, “Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level,” Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1558–1565, 2001. View at Google Scholar · View at Scopus
  4. P. Ronco, E. Plaisier, B. Mougenot, and P. Aucouturier, “Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 6, pp. 1342–1350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. P. Grassi, F. Clerici, C. Perin et al., “Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient,” Italian Journal of Neurological Sciences, vol. 19, no. 4, pp. 229–233, 1998. View at Google Scholar · View at Scopus
  6. H. Hassoun, C. Flombaum, V. D. D'Agati et al., “High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease,” Bone Marrow Transplantation, vol. 42, no. 6, pp. 405–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Weichman, L. M. Dember, T. Prokaeva et al., “Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation,” Bone Marrow Transplantation, vol. 38, no. 5, pp. 339–343, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Katoh, M. Matsuda, T. Yoshida et al., “Primary Al amyloid polyneuropathy successfully treated with high-dose melphalan followed by autologous stem cell transplantation,” Muscle and Nerve, vol. 41, no. 1, pp. 138–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Bladé, M. T. Cibeira, and L. Rosiñol, “Bortezomib: a valuable new antineoplastic strategy in multiple myeloma,” Acta Oncologica, vol. 44, no. 5, pp. 440–448, 2005. View at Publisher · View at Google Scholar · View at Scopus